These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4465784)

  • 1. Trade names or approved names. Point II. Points of view. The clinical pharmacologist.
    Turner P
    Postgrad Med J; 1974 Feb; 50(580):93-5. PubMed ID: 4465784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation.
    Beckett AH
    Postgrad Med J; 1974 Feb; 50(580):125-9. PubMed ID: 4465774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trade names or approved names. Part II. Points of view. Europe.
    Grainger HS
    Postgrad Med J; 1974 Feb; 50(580):73-6. PubMed ID: 4465777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trade names or approved names. Part III. Special cases. Clinical trials.
    Garnham JC
    Postgrad Med J; 1974 Feb; 50(580):114-20. PubMed ID: 4465771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trade names or approved names. Part III. Special cases. The digoxin affair.
    Shaw TR
    Postgrad Med J; 1974 Feb; 50(580):98-102. PubMed ID: 4465786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trade names or approved names. Part II. Points of view. The pharmaceutical company.
    Hoare RG
    Postgrad Med J; 1974 Feb; 50(580):85-7. PubMed ID: 4465781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability studies and the clinical pharmacologist: correlation of drug distribution with clinical effects.
    Ogilvie RI
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):349-54. PubMed ID: 1099026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trade names or approved names. Part III. Special cases. Antibiotics.
    Garrod LP
    Postgrad Med J; 1974 Feb; 50(580):96-7. PubMed ID: 4465785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are all warfarin preparations Alike? A comprehensive overview of current data, emerging opinions, and perspectives.
    GiaQuinto NJ
    J Thromb Thrombolysis; 2000 Feb; 9(2):139-44. PubMed ID: 10613994
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Bio-availability and clinical efficacy of a drug.
    Ganguli LK
    J Indian Med Assoc; 1973 Jul; 61(2):94-5. PubMed ID: 4759083
    [No Abstract]   [Full Text] [Related]  

  • 11. Trade names or approved names. Part II. Points of view. The hospital pharmacist.
    Baker JA
    Postgrad Med J; 1974 Feb; 50(580):83-4. PubMed ID: 4465780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiolical availability of medicinal agents in tablets and appraisal of their quality tests].
    Mikhaĭlova GS
    Farmatsiia; 1974; 23(1):80-3. PubMed ID: 4817322
    [No Abstract]   [Full Text] [Related]  

  • 13. Trade names and generic names. Problems for prescribing physicians.
    Hemminki E; Enlund H; Hellevuo K; Laurila R; Turakka H
    Scand J Prim Health Care; 1984 May; 2(2):84-7. PubMed ID: 6544453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biopharmaceutics and drug formulation].
    Riccieri FM
    Ann Ist Super Sanita; 1982; 18(3):541-6. PubMed ID: 7187842
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the availability of six commercial formulations of isoniazid.
    Gelber R; Jacobsen P; Levy L
    Clin Pharmacol Ther; 1969; 10(6):841-8. PubMed ID: 5349625
    [No Abstract]   [Full Text] [Related]  

  • 17. [Formulation of tablets and bioavailability: a biologic method of evaluation].
    Lévy-Appert-Collin M; Willemin JC; Lévy J
    Pharm Acta Helv; 1976; 51(11):348-51. PubMed ID: 1019179
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary. Reflections in a crystal ball.
    Lasagna L
    Clin Pharmacol Ther; 1975 Jul; 18(1):1-8. PubMed ID: 1097147
    [No Abstract]   [Full Text] [Related]  

  • 19. [Editorial: Biologic availability--aspects related to general practice].
    Schmidt R
    Schweiz Rundsch Med Prax; 1974 Jun; 63(23):697-8. PubMed ID: 4838647
    [No Abstract]   [Full Text] [Related]  

  • 20. Trade names or proper names? A problem for the prescriber.
    Huskisson EC
    Br Med J; 1973 Oct; 4(5886):225-8. PubMed ID: 4758398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.